×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Maps
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
After $2B acquisition, GSK sends some Bellus workers packing
Fierce Biotech
After GSK's $2 billion buyout of Canada-based Bellus Health, an undisclosed number of the biotech's team members are out of a job.
1 month ago
BELLUS (BLU) Completes Enrollment in Two Mid-Stage Studies
Yahoo Movies UK
BELLUS Health Inc. BLU recently announced that it has completed patient enrollment in two ongoing mid-stage studies on pipeline candidate,...
4 days ago
After Merck's cough drama, GSK knew what to do with Bellus asset
Fierce Biotech
By the time GSK sealed the deal on Bellus Health in April, the U.K. pharma knew exactly what not to do with the phase 3 chronic cough...
5 months ago
With $1.2B stock sale, GSK offloads more of its stake in consumer health spinoff Haleon
Fierce Pharma
GSK is sticking to its plan to gradually monetize its stake in Haleon, the consumer health business the British pharma giant spun off in...
4 months ago
GSK acquires biopharmaceutical company Bellus Health - News
The Chemical Engineer
GSK has completed the acquisition of Bellus Health, a Canada-based, late-stage biopharmaceutical company that developed a drug that could...
10 months ago
GSK Acquires BELLUS Health
PharmTech
This arrangement was approved by the shareholders at BELLUS on June 16, 2023, according to a company press release.
10 months ago
GSK bets $2 bln on Bellus cough drug to soothe pipeline fears
Reuters
GSK plans to buy Canada-based drug developer Bellus Health Inc in an all-cash deal for $2 billion as the British drugmaker expands its bet...
12 months ago
How Much Did BELLUS Health Inc.'s (TSE:BLU) CEO Pocket Last Year?
Yahoo Life UK
Roberto Bellini became the CEO of BELLUS Health Inc. (TSE:BLU) in 2010. First, this article will compare CEO compensation with compensation...
1 week ago
GSK Acquires Bellus Health for $2 Billion
PharmaNewsIntel
GSK Acquires Bellus Health for 2 Billion Dollars, Pharmaceutical Acquisition.
12 months ago
GSK agrees to buy BELLUS Health for $2bn
Pharmaceutical Technology
GSK has signed an agreement to buy Canadian late-stage biopharmaceutical company BELLUS Health for $2bn (£1.6bn).
12 months ago